IFNA1 and neoplasm: In sharp contrast, treatment of tumor‐bearing mice with IFN‐α/β or 34 by themselves did not bring about a significant regression of tumor size.194 Collectively, the conducted studies show a limited efficacy and dose‐dependent toxicity of therapeutic cytokines in anticancer therapy.